Tang Capital Management’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.9M Buy
1,418,984
+318,984
+29% +$4.26M 0.96% 33
2025
Q1
$11.2M Buy
+1,100,000
New +$11.2M 0.62% 42